GENERAL COMMENTARY article
Erratum: Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers
- 1Axe Neurosciences, Centre de recherche du CHU de Québec (CHUL), Quebec, QC, Canada
- 2Département de psychiatrie et de neurosciences, Université Laval, Quebec, QC, Canada
by Dorval, V., Nelson, P. T., and Hébert, S. S. (2013). Front. Mol. Neurosci. 6:24. doi: 10.3389/fnmol.2013.00024
An error has been pointed out under the section CSF after our mini-review was published. At the end of the last paragraph, the reported correlations have been wrongly assigned to Alexandrov et al. The correct citation for this work is “Geekiyanage, H., and Chan, C. (2011). MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci. 31, 14820–14830. doi: 10.1523/JNEUROSCI.3883-11.2011.” However, these results were obtained from the study of frontal cortices of Alzheimer's patients, not the CSF. Thus, caution should be taken with regards to this work, which is unfortunately no longer in the scope of the present mini-review on circulating microRNAs as biomarkers.
Keywords: microRNA, Alzheimer's disease, biomarker, diagnosis, mild cognitive impairment
Citation: Dorval V (2013) Erratum: Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers. Front. Mol. Neurosci. 6:38. doi: 10.3389/fnmol.2013.00038
Received: 23 October 2013; Accepted: 24 October 2013;
Published online: 11 November 2013.
Edited by:Hermona Soreq, The Hebrew University of Jerusalem, Israel
Copyright © 2013 Dorval. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.